fda removes semaglutide from shortage list ends as sets deadline for compounders FDA declares semaglutide (Ozempic/Wegovy) shortage

3,13 The symptom location will also vary depending on the substances contact location

It also points to the need for better strategies to make these treatments more accessible and available to those who need them. Prior to this research, a small study of 106 postmenopausal women published in 2024 in the medical journal Menopause found that those who were on both MHT and the GLP-1 drug semaglutide had lost about 16 percent of their total body weight after a year, compared to 12 percent for women on a GLP-1 alone

For self-injection, the abdomen and thigh are recommended

Some patients also explore alternative medications within the GLP-1 class